Long-term remission after autologous stem-cell transplantation for relapsed histiocytic sarcoma

被引：14

作者：

Abu-Sanad, A. ^{[1
]}

Warsi, A. ^{[2
]}

Michel, R. P. ^{[3
]}

Nahal, A. ^{[3
]}

Popradi, G. ^{[2
]}

Storring, J. M. ^{[2
]}

Liberman, A. S. ^{[4
]}

Alcindor, T. ^{[1
,2
]}

机构：

[1] McGill Univ, Div Med Oncol, Ctr Hlth, Montreal, PQ, Canada

[2] McGill Univ, Div Hematol, Ctr Hlth, Montreal, PQ, Canada

[3] McGill Univ, Dept Pathol, Ctr Hlth, Montreal, PQ, Canada

[4] McGill Univ, Div Colorectal Surg, Ctr Hlth, Montreal, PQ, Canada

来源：

CURRENT ONCOLOGY | 2012年 / 19卷 / 04期

关键词：

Histiocytic sarcoma; chemotherapy; stem-cell transplantation;

D O I：

10.3747/co.19.964

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Histiocytic sarcoma is diagnosed according to established criteria. However, treatment is controversial: although lymphoma chemotherapy regimens are often used, their impact on the natural history of the disease is unclear. Here, we report a disease-free survival of 2 years after autologous stem-cell transplantation in a patient with relapsed histiocytic sarcoma.

引用

页码：E289 / E291

页数：3

共 9 条

[1] Thalidomide for the treatment of histiocytic sarcoma after hematopoietic stem cell transplant [J].

Abidi, Muneer H. ;

Tove, Isaacson ;

Ibrahim, Raml B. ;

Maria, Dan ;

Peres, Edward .

AMERICAN JOURNAL OF HEMATOLOGY, 2007, 82 (10) :932-933

[2]

CAZIN B, 1990, BONE MARROW TRANSPL, V5, P431

[3] Autologous Hematopoietic Stem-Cell Transplantation in Combination With Thalidomide As Treatment for Histiocytic Sarcoma: A Case Report and Review of the Literature [J].

Gergis, Usama ;

Dax, Hendrik ;

Ritchie, Ellen ;

Marcus, Rachel ;

Wissa, Usama ;

Orazi, Attilio .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (10) :E251-E253

[4]

Hornick JL, 2002, HISTOPATHOLOGY, V41, P1

[5] A case of resistant pediatric histiocytic sarcoma successfully treated with chemo-radiotherapy and autologous peripheral blood stem cell transplant [J].

Mainardi, Chiara ;

D'Amore, Emanuele S. G. ;

Pillon, Marta ;

Toffolutti, Tiziana ;

Rosolen, Angelo .

LEUKEMIA & LYMPHOMA, 2011, 52 (07) :1367-1371

[6] Tumours of histiocytes and accessory dendritic cells:: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases [J].

Pileri, SA ;

Grogan, TM ;

Harris, NL ;

Banks, P ;

Campo, E ;

Chan, JKC ;

Favera, RD ;

Delsol, G ;

De Wolf-Peeters, C ;

Falini, B ;

Gascoyne, RD ;

Gaulard, P ;

Gatter, KC ;

Isaacson, PG ;

Jaffe, ES ;

Kluin, P ;

Knowles, DM ;

Mason, DY ;

Mori, S ;

Müller-Hermelink, HK ;

Piris, MA ;

Ralfkiaer, E ;

Stein, H ;

Su, IJ ;

Warnke, RA ;

Weiss, LM .

HISTOPATHOLOGY, 2002, 41 (01) :1-29

[7] Histiocytic sarcoma: a study of five cases including the histiocyte marker CD163 [J].

Vos, JA ;

Abbondanzo, SL ;

Barekman, CL ;

Andriko, JW ;

Miettinen, M ;

Aguilera, NS .

MODERN PATHOLOGY, 2005, 18 (05) :693-704

[8] A Case of Primary Histiocytic Sarcoma Arising from Thyroid Gland [J].

Yu, Lu ;

Yang, Shou Jing .

PATHOLOGY & ONCOLOGY RESEARCH, 2010, 16 (01) :127-132

[9]

Zhai M, 1997, Zhonghua Xue Ye Xue Za Zhi, V18, P395

← 1 →